Induction chemotherapy backbone in frail patients with advanced NSCLC treated with chemotherapy plus pembrolizumab: a single institution retrospective audit of dose intensities from modified regimens.

Autor: Cortellini A; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy.; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom., Citarella F; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy.; Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST), Meldola, Italy., Vendittelli A; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Fiorenti M; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Mingo EC; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Cascetta P; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., La Cava G; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Santo V; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Brunetti L; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Di Fazio GR; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Fioroni I; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy., Pantano F; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Vincenzi B; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy., Russano M; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy., Minotti G; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy.; Operative Research Unit of Clinical Pharmacology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy., Tonini G; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy.; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy.

Publikováno v: Journal of chemotherapy (Florence, Italy) [J Chemother] 2024 Aug 06, pp. 1-9. Date of Electronic Publication: 2024 Aug 06.